Beida pharmaceutical: clinical trial of batirizumab injection in the treatment of cervical cancer approved
Beida pharmaceutical announced that the company and Agnus jointly declared the evaluation of clinical trials of balstilimab injection (PD-1 antibody) alone or combined with zalifrelimab injection (CTLA-4 antibody) in the treatment of advanced cervical cancer, which has been approved by nmpa.
This text is a result of machine translation.
Related companies：
In-depth
Consumer Staples
The Billion-Dollar European Caviar Business, Now Disrupted by China
In the kitchen of a Michelin three-star restaurant in Beijing, the chef carefully opens a tin of black "treasures." Each translucent caviar pearl inside is immensely valuable, with prices reaching as high as 10,000 RMB per kilogram. Yet this "black gold" caviar does not come from the Caspian Sea or the Volga River. Instead, it originates from Quzhou, Zhejiang, China. This seemingly impossible fact marks a silent revolution in the Chinese caviar industry.
Nov 08, 2024 01:52 PM
Dec 11, 2023 08:49 PM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Briefing Nov 29, 2021 07:59 PM
· Healthcare
Boten Co., Ltd.: direnavir API has passed who PQ certification
Briefing Aug 31, 2021 08:59 PM
TECO shares: obtained an invention patent certificate
Financials
Indonesian Rupiah Plunges 1.2% Against USD, Outpacing Ringgit's Decline
Dec 19, 2024 04:59 PM
Consumer Staples
Lack of Trust in AI Tech Leads Singaporean Companies to Cut Investments
Dec 19, 2024 04:50 PM
Financials
Indonesia to Establish 7 to 9 New Economic Zones Over the Next Four Years to Boost Growth
Indonesia plans to establish 7 to 9 new economic zones over the next four years as part of its strategy to attract more investment and drive economic growth, according to Coordinating Minister for Economic Affairs, Airlangga Hartarto.
Dec 12, 2024 03:54 PM
Briefing Jul 07, 2021 03:24 PM
· Healthcare
The first bank of China fund to release its second Quarterly Report
Briefing Dec 11, 2020 08:17 PM
· Healthcare
Beida pharmaceutical: the three shareholders intend to reduce the shares of the company no more than 2.31%
See more
Read next
Insight
In-depth
Insight
In-depth
Consumer Discretionary
Amazon Global Selling: A Decade of Growth in a Vast Market
Dec 17, 2024 05:43 PM
Insight
In-depth
Consumer Staples · Analysis
Din Tai Fung and the Globalization of Chinese Cuisine
Dec 03, 2024 08:26 PM
Insight
In-depth
Communication · Analysis
Podcast Marketing, A Useful Tool for Companies Going Overseas
Dec 02, 2024 02:15 PM